Impact of Ferumoxytol Magnetic Resonance Imaging on the Rhesus Macaque Maternal-Fetal Interface
S. M. Nguyen, G. J. Wiepz, M. Schotzko, H. A. Simmons, A. Mejia, K. D. Ludwig, A. Zhu, K. Brunner, D. Hernando, S. B. Reeder, O. Wieben, K. Johnson, D. Shah, T. G. Golos
Abstract
Ferumoxytol is a superparamagnetic iron oxide nanoparticle (SPION) used off-label as an intravascular magnetic resonance imaging (MRI) contrast agent. Additionally, ferumoxytol-uptake by macrophages facilitates detection of inflammatory sites by MRI through ferumoxytol-induced image contrast changes. Therefore, ferumoxytol-enhanced MRI holds great potential for assessing vascular function and inflammatory response, critical to determine placental health in pregnancy. This study sought to assess the fetoplacental unit and selected maternal tissues, pregnancy outcomes, and fetal well-being after ferumoxytol administration. In initial developmental studies, pregnant rhesus macaques were imaged with and without ferumoxytol administration. Pregnancies went to term with vaginal delivery and infants showed normal growth rates compared to control animals born the same year that did not undergo MRI. To determine the impact of ferumoxytol on the maternal-fetal interface, fetal well-being, and pregnancy outcome, four pregnant rhesus macaques at [~]100 gd (gestational day) underwent MRI before and after ferumoxytol administration. Collection of the fetoplacental unit and selected maternal tissues was performed 3-4 days following ferumoxytol administration. A control group that did not receive ferumoxytol or MRI was used for comparison. Iron levels in fetal and maternal-fetal interface tissues did not vary between groups. There was no significant difference in tissue histopathology with or without exposure to ferumoxytol, and no effect on placental hormone secretion. Together, these results suggest that the use of ferumoxytol and MRI in pregnant rhesus macaques will not introduce a detectable risk to the mother or fetus at the time of imaging or up to one year following normal vaginal delivery.\n\nSummary SentenceFerumoxytol magnetic resonance imaging for non-invasive pregnancy monitoring of the rhesus macaque does not impact histopathology or iron content of the maternal-fetal interface.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ferumoxytol dynamic contrast-enhanced MRI for in vivo longitudinal cotyledon perfusion assessment with pathology correlation in a rhesus macaque thrombotic injury model
Ruo-Yu Liu, Logan T. Keding, … Oliver E. Wieben·PlacentaPeer-reviewed·Sep 23, 2026
- Nanoparticle-mediated delivery of placental gene therapy via uterine artery catheterization in a pregnant rhesus macaque
Jenna Kropp Schmidt, Rebecca L. Wilson, … Helen N Jones·PlacentaPeer-reviewed·Apr 14, 2024
- Bridging Cotyledon Pathology and Perfusion in Healthy Primate Pregnancy
Logan T. Keding, Ruo-Yu Liu, … Aleksandar K. Stanic·bioRxiv·May 21, 2026
- A potent myeloid response is rapidly activated in the lungs of premature Rhesus macaques exposed to intra-uterine inflammation
C. M. Jackson, M. Demmert, … C. A. Chougnet·Mucosal ImmunologyPeer-reviewed·Apr 1, 2022
- Modeling Normal Mouse Uterine Contraction and Placental Perfusion with Non- invasive Longitudinal Dynamic Contrast Enhancement MRI
Devin Raine Everaldo Cortes, Margaret Caroline Stapleton, … Yijen Lin Wu·PLoS ONEPeer-reviewed·Jul 1, 2024
- Delineating the effects of prenatal oxycodone exposure and melatonin treatment on placental and fetal outcomes in pregnant rats
Isaac Oluwole Adediji, Hager M. Kowash, … Lynda K. Harris·bioRxiv·Apr 27, 2026